Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
GD3
ganglioside induces apoptosis in several cell types, but the molecular events through which this occurs are largely unknown. We investigated the apoptotic effects of
GD3
expression using U-1242 MG glioblastoma cells, as these cells synthesize almost exclusively GM3 and GM2 but not
GD3
. To express
GD3
under the control of the TetOn system with minimum leakage, we modified the system by constructing a single tri-cistronic retrovirus vector containing three genes separated by two internal ribosome entry sites: (a) transcriptional silencer, tTS; (b) mutant of reverse
transcriptional activator
, rtTA2(S)-M2 (provided by H. Bujard, Heidelberg, Germany); and (c) enhanced green fluorescent protein (EGFP), as an indicator of the tri-cistronic gene expression. Using flow cytometry, we selected glioma cells (U1242MG-
GD3
clone) that express high levels of
GD3
in response to doxycycline. Expression of
GD3
was associated with apoptosis as verified by annexin-V binding, TdT-mediated dUTPnick end-labelling assay (TUNEL), and EGFP degradation.
GD3
-induced apoptosis occurred via caspase-8 activation, as
GD3
caused cleavage of caspase-8 and inhibition of caspase-8 activation by zlETD-fmk minimized
GD3
-induced apoptosis.
...
PMID:Endogenous GD3 ganglioside induces apoptosis in U-1242 MG glioma cells. 1644 17